Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 1, 2005, Pages 109-118

  Tabar, Ana Isabel ^a   Echechipía, Susana ^a,c   García, Blanca Esther ^a   Olaguibel, José María ^a   Lizaso, Maria Teresa ^a   Gómez, Belén ^a   Aldunate, Maria Teresa ^a   Martin, Santiago ^b   Marcotegui, Fernando ^a  

^a Universidad Pública de Navarra   (Spain)

^b ALK ABELLÓ   (Denmark)

^c CS Conde Oliveto ^*  (Spain)

Author keywords

Adults; Children; Clinical efficacy; Cluster immunotherapy; Conventional immunotherapy; Double blind study; Kinetics; Safety; Skin prick test; Specific immunoglobulins

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; INJECTION SITE REACTION; MALE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; STANDARDIZATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALLERGENS; ANTIGENS, DERMATOPHAGOIDES; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION SCHEDULE; MALE; SKIN TESTS; TREATMENT OUTCOME;

EID: 21344467468     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.05.005     Document Type: Article

References (50)

1. H.J. Malling Immunotherapy as an effective tool in allergy treatment Allergy 53 1998 461 472
2. Immunotherapy Subcommittee of the EAACI Immunotherapy Allergy 48 suppl 14 1993 1 45
3. J. Bousquet, R.F. Lockey, and H.G. Malling WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases Allergy 53 suppl 44 1998 1 42
4. M.J. Abramson, R. Puy, and J. Weiner Immunotherapy in asthma: an updated systematic review Allergy 54 1999 1022 1041
5. C. Vidal, L. Fernández-Távora, C. Moreno, and P. Guardia Inmunoterapia cluster con extracto depot de Dermatophagoides pteronyssinus: estudio prospectivo de tolerancia Rev Esp Alergol Inmunol Clin 12 1997 351 355
6. M.T. Mellerup, G.W. Hahn, L.K. Poulsen, and H.J. Malling Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment Clin Exp Allergy 30 2000 1423 1429
7. C. Moreno, L. Fernández-Távora, C. Vidal, J.L. Justicia, and F. Guerra Estudio prospectivo de seguridad de inmunoterapia agrupada con extractos acuosos de pólenes Allergol Immunol Clin 16 2001 95 101
8. P. García-Ortega, A. Merelo, J. Marrugat, and C. Richart Decrease of skin and bronchial sensitization following short-intensive scheduled immunotherapy in mite-allergic asthma Chest 103 1993 183 187
9. S.M. Walker, G.B. Pajno, M. Torres Lima, D.R. Wilson, and S.R. Durham Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial J Allergy Clin Immunol 107 2001 87 93
10. D. Muñoz, G. Bernaola, M. Audícana, E. Fernández, and L. Fernández de Corres Inmunoterapia rápida en pacientes polínicos. Evolución clínica y variación de parámetros in vivo e in vitro Rev Esp Alergol Inmunol Clin 6 suppl 1 1991 57 61
11. L. Fernández-Távora, and D. García Inmunoterapia Cluster con extractos de pólenes: estudios de tolerancia, cambios inmunológicos y eficacia clínica Rev Esp Alergol Inmunol Clin 6 suppl 1 1991 68 74
12. H.J. Malling, S. Dreborg, and B. Weeke Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum Allergy 41 1986 507 519
13. A.I. Tabar, M.D. Muro, B.E. García, M.J. Alvarez, S. Acero, and P. Rico Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy Invest Allergol Clin Immunol 9 1999 155 164
14. S.M. McHugh, J. Deighton, A.G. Stewart, P.J. Lachmann, and P.W. Ewan Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy Clin Exp Allergy 25 1995 828 838
15. W.J. Stevens, J.A. Verhelst, W. van den Bogaert, and C.H. Bridts Clinical and biological evaluation of semi-rush and ordinary immunotherapy schemes in type I allergic respiratory diseases Allergy 40 1985 447 452
16. International consensus report on the diagnosis and management of rhinitis Allergy 49 suppl 19 1994 1 34
17. National Institutes of Health 1995 Epidemiology En: Global Initiative for Asthma: global strategy for asthma management and prevention (National Institutes of Health, National Heart, Lung and Blood Institute and World Health Organisation Workshop Report) 1995 National Institutes of Health Bethesda (MD) NIH publication no. 95-3659
18. P. Ventas, M. Lombardero, O. Duffort, and J. Carreira Cuantificación de los alergenos Der p 1 y Der f 1 de los ácaros y Fel d 1 de gato mediante un ELISA en fase sólida Rev Esp Alergol Inmunol Clin 13 1998 280 281
19. K. Aas Heterogeneity of bronchial asthma Allergy 36 1981 3 14
20. E.O. Meltzer Evaluating rhinitis: clinical, rhinomanometric and cytologic assessments J Allergy Clin Immunol 82 1988 900 908
21. S. Echechipía, A.I. Tabar, T. Lobera, D. Muñoz, A. Rodriguez, and A. Blasco Immunotherapy with a standardized Dermatophagoides pteronyssinus glutaraldehyde-modified extract against an unmodified extract: a comparative study of efficacy, tolerance and in vivo and in vitro modification of parameters J Invest Allergol Clin Immunol 5 1995 325 332
22. J.M. Olaguibel, A.I. Tabar, B.E. García Figueroa, and C. Cortés Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose-titration study Allergy 52 1997 168 178
23. J.M. Olaguibel, A.I. Tabar, B.E. García, S. Martín, and P. Rico Long-term immunotherapy with an optimal maintenance dose of a standardized Dermatophagoides pteronyssinus extract in asthmatic patients Invest Allergol Clin Immunol 9 1999 110 116
24. P. Rico, C. Vidal, T. Carrillo, A. Beristain, and P. Cuesta Evaluación de una cartilla de síntomas y medicación: consistencia interna y relación con la valoración clínica del médico y del paciente Rev Esp Alergol Inmunol Clin 13 suppl 2 1998 280 281
25. Adams NP, Bestall JB, Jones PW. Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev 2000;(4):CD002738.
26. W.W. Busse, P. Chervinsky, J. Condemi, W.R. Lumry, T.L. Petty, and S. Rennard Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma J Allergy Clin Immunol 101 1998 457 463
27. N.H. Gershman, H.H. Wong, J.T. Liu, and J.V. Fahy Low- and high-dose fluticasone propionate in asthma; effects during and after treatment Eur Respir J 15 2000 11 18
28. J.C. Virchow, A. Prasse, I. Naya, L. Summerton, and A. Harris Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids Am J Respir Crit Care Med 162 2000 578 585
29. A.S. Rebuck, S. Kesten, L.P. Boulet, A. Cartier, D. Cockcroft, and J. Gruber A 3 month evaluation of the efficacy of nedocromil sodium in asthma: a randomized double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group J Allergy Clin Immunol 85 1990 612 617
30. J.M. Weiner, M.J. Abramson, and R.M. Puy Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials BMJ 317 1998 1624 1629
31. J.J. Quackenboss, M.D. Lebowitz, and M. Krzyzanowski The normal range of diurnal changes in peak expiratory flow rates: relationship to symptoms and respiratory diseases Am Rev Respir Dis 143 1991 323 330
32. S. Dreborg Skin tests used in type 1 allergy skin testing. Position Paper of the European Academy of Allergy and Clinical Immunology Allergy 44 suppl 10 1989 22 39
33. European Academy of Allergy and Clinical Immunology (EAACI) Subcommittee on Skin Tests. Position paper. Allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology Allergy 48 suppl 14 1993 48 82
34. S. Martin, P. Cuesta, P. Rico, and C. Cortés A computer program based on parallel line assay for analysis of skin tests Allergy 52 1997 97 100
35. P.J. Chowienczyk, D.H. Parkin, C.P. Lawson, and G.M. Cochrane Do asthmatic patients correctly record home spirometry measurements? BMJ 309 1994 1618
36. J.E. Gern, P.A. Eggleston, K.C. Schuberth, N.D. Eney, E.O. Goldstein, and M.E. Weiss Peak flow variation in childhood asthma: a three-year analysis J Allergy Clin Immunol 93 1994 706 716
37. J. Bousquet, H. Maasch, B. Martinot, A. Hejjaoui, R. Wahl, and F.B. Michel Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy J Allergy Clin Immunol 82 1988 439 446
38. L. Antonicelli, S. Pucci, M.B. Biló, M.S. Garritani, and F. Bonifazi Early decrease in skin reactivity after rush venom immunotherapy J Invest Allergol Clin Immunol 4 1994 57 60
39. M.D. Muro, A.I. Tabar, M.T. Lizaso, S. Quirce, F. Polo, and B.E. García Cluster versus conventional immunotherapy in patients allergic to Dermatophagoides pteronyssinus: a controlled study of in vivo and in vitro parameters Invest Allergol Clin Immunol 9 1999 146 154
40. P.A. Ewbank, J. Murray, K. Sanders, D. Curran-Everett, S. Dreskin, and H.S. Nelson A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract J Allergy Clin Immunol 111 2003 155 161
41. A. Nanda, M. O'Connor, M. Anand, S. Dreskin, L. Zhang, and B. Hines Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract J Allergy Clin Immunol 114 2004 1339 1344
42. S.R. Durham, and S.J. Till Immunologic changes associated with allergen immunotherapy J Allergy Clin Immunol 102 1998 157 164
43. C. Ebner Immunological mechanisms operative in allergen-specific immunotherapy Int Arch Allergy Immunol 119 1999 1 5
44. S. Paranos, and S. Petrovic Early effects of rush immunotherapy with Dermatophagoides pteronyssinus in asthmatics J Invest Allergol Clin Immunol 7 1997 588 595
45. B.E. García, M.L. Sanz, E. Wong, and A. Oehling Effect of immunotherapy on antigen-specific IgG4 in asthmatics sensitive to D. pteronyssinus Allergol Immunopathol 16 1988 379 383
46. N. Mothes, M. Heinzkill, K.J. Drachenberg, W.R. Sperr, M.T. Krauth, and Y. Majlesi Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies Clin Exp Allergy 33 2003 1198 1208
47. R.J. Van Neerven, T. Wikborg, G. Lund, B. Jacobsen, A. Brinch-Nielsen, and J. Arnved Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation J Immunol 163 1999 2944 2952
48. A.I. Tabar, B.E. García, A. Rodriguez, J.M. Olaguibel, M.D. Muro, and S. Quirce A prospective safety-monitoring study of immunotherapy with biologically standardized extracts Allergy 48 1993 450 453
49. A.I. Tabar, S. Echechipía, B.E. García, J.M. Olaguibel, B. Gómez, and E. Lasa Safety-monitoring of allergen-specific immunotherapy with standardized extracts. A prospective and predictive study in 7000 patients [abstract] Allergy 56 suppl 68 2001 91
50. I. Sánchez, J.C. García, C. Bonnet, C. de Blas, E. Fernández-Caldas, and M. Sánchez Immunotherapy units: a follow-up study Invest Allergol Clin Immunol 11 2001 167 171